Zobrazeno 1 - 10
of 1 578
pro vyhledávání: '"ibandronate"'
Autor:
Mollaamin, Fatemeh, Monajjemi, Majid
Publikováno v:
Sensor Review, 2024, Vol. 44, Issue 2, pp. 100-112.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/SR-05-2023-0148
Publikováno v:
Journal of Bone Oncology, Vol 47, Iss , Pp 100624- (2024)
Background: The Radiotherapy IBandronate (RIB) trial compared single dose radiotherapy and a single infusion of ibandronate in 470 bisphosphonate naïve patients with metastatic bone pain from prostate cancer randomised into a non-inferiority two arm
Externí odkaz:
https://doaj.org/article/481a72e7759c4357b0ffe4c1b1705888
Autor:
Opinder Sahota, Melanie Narayanasamy, Anastasios Bastounis, Zoe Paskins, Simon Bishop, Tessa Langley, Neil Gittoes, Sarah Davis, Ann Baily, Moira Holmes, Jo Leonardi-Bee
Publikováno v:
Health Technology Assessment, Vol 28, Iss 21 (2024)
Background Bisphosphonates are a class of medication commonly used to treat osteoporosis. Alendronate is recommended as the first-line treatment; however, long-term adherence (both treatment compliance and persistence) is poor. Alternative bisphospho
Externí odkaz:
https://doaj.org/article/c1326e0d2c6c408c8d5ea0465afeae9e
Autor:
O. A. Nikitinskaya, N. V. Toroptsova
Publikováno v:
Современная ревматология, Vol 16, Iss 4, Pp 105-110 (2022)
Osteoporosis (OP) occupies one of the leading places in the structure of morbidity in people over 50 years of age, and its social significance is associated with the main complications – low-energy fractures of the vertebral bodies and bones of the
Externí odkaz:
https://doaj.org/article/5312f295de364623a622c5167dc28278
Autor:
Mohammed K. Afifi, Ahmed S. Kenawy, Heba H. El Demellawy, Amany A. Azouz, Torki Al-Otaibi, Osama Gheith, Mohamed Abd ElMonem, Mohamed S. AbdElhalim, Raghda R. S. Hussein
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Osteoporosis and osteopenia occur frequently in renal transplant recipients due to long-term use of immune-suppressants including corticosteroids. Previous treatment options like bisphosphonates had acceptable but rather unsatisfa
Externí odkaz:
https://doaj.org/article/43a3a8f01b2a442087716d99e6b0b46f
Autor:
I. V. Kuznetsova, R. A. Chilova
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 320-331 (2021)
Osteoporosis represents a great healthcare challenge due to an increased risk of fragility fractures that significantly decreases quality of life, shortens life expectancy, and looms as an onerous burden on both the social environment of patients and
Externí odkaz:
https://doaj.org/article/299014f7345d4f8eb0fc5f87ae12b94e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fatemeh Mollaamin, Majid Monajjemi
Publikováno v:
C, Vol 9, Iss 2, p 61 (2023)
Bisphosphonate (BP) agents have attracted much attention for their precise therapy in some skeletal maladies demonstrated by enhancing osteoclast-mediated bone resorption. In this work, the use of CAM-B3LYP/6-311+G(d,p)/LANL2DZ to estimate the suscep
Externí odkaz:
https://doaj.org/article/059785427f3a423593a349e62ee57034
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract Background Lumbar spinal stenosis (LSS) can cause various neurological symptoms and reduce the daily activity of patients. Many studies have shown that free physical activities and exercise can improve bone mineral density (BMD) in patients
Externí odkaz:
https://doaj.org/article/2be2b4be2ad640f4b8b8d66f75fd3082